| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | Jun 21, 2025 | Lamy Patrick SVP Commercial Strategy | Sell | Akero Therapeutics, Inc. | AKRO | $54.59 | $47,766 | -2.69% |
| Jun 16, 2025 | Jun 20, 2025 | Lamy Patrick SVP Commercial Strategy | Sell | Akero Therapeutics, Inc. | AKRO | $54.14 | $108,272 | -5.78% |
| Jun 10, 2025 | Jun 12, 2025 | Lamy Patrick SVP Commercial Strategy | Sell | Akero Therapeutics, Inc. | AKRO | $54 | $49,625 | -2.74% |
| Jun 02, 2025 | Jun 04, 2025 | Lamy Patrick SVP Commercial Strategy | Sell | Akero Therapeutics, Inc. | AKRO | $50.31 | $201,258 | -10.67% |
| May 22, 2025 | May 23, 2025 | Lamy Patrick SVP Commercial Strategy | Sell | Akero Therapeutics, Inc. | AKRO | $50 | $200,000 | -10.67% |
| May 07, 2025 | May 09, 2025 | Lamy Patrick SVP Commercial Strategy | Sell | Akero Therapeutics, Inc. | AKRO | $42.49 | $339,950 | -19.28% |
| Mar 03, 2025 | Mar 05, 2025 | Lamy Patrick SVP Commercial Strategy | Sell | Akero Therapeutics, Inc. | AKRO | $48.09 | $48,090 | -2.90% |
| Jan 27, 2025 | Jan 30, 2025 | Lamy Patrick SVP Commercial Strategy | Sell | Akero Therapeutics, Inc. | AKRO | $57.03 | $285,150 | -12.99% |
| Dec 16, 2024 | Dec 19, 2024 | Lamy Patrick SVP Commercial Strategy | Sell | Akero Therapeutics, Inc. | AKRO | $29.13 | $29,130 | -2.84% |
| Dec 10, 2024 | Dec 13, 2024 | Lamy Patrick SVP Commercial Strategy | Sell | Akero Therapeutics, Inc. | AKRO | $30.79 | $28,481 | -4.92% |
| Jun 11, 2024 | Jun 13, 2024 | Lamy Patrick SVP Commercial Strategy | Sell | Akero Therapeutics, Inc. | AKRO | $22.64 | $12,883 | -2.97% |